Manoj S Nair, etc., al. Serum neutralisation of H5N1 clade 2.3.4.4b influenza is largely mediated by neuraminidase-directed antibodies. The Lancet Microbe
Highly pathogenic avian influenza A (H5N1) continues to circulate globally in avian and mammalian species. Since its emergence in 1997, over 1000 confirmed human infections with H5N1 have been reported, with a case-fatality rate of approximately 50%. In recent years, H5N1 clade 2.3.4.4b viruses have caused extensive outbreaks in wild birds and poultry, resulting in the culling of hundreds of millions of birds. This influenza lineage has also expanded into mammalian hosts, including widespread outbreaks in American dairy cattle and over 70 confirmed human infections in the USA, with two fatalities. The rapid global dissemination and expanding host range of H5N1 clade 2.3.4.4b have raised genuine concerns about its pandemic potential.
See Also:
Latest articles in those days:
- Determinants of the Seasonal Influenza Vaccination Uptake Among People Aged 50 Years or Above During and After the Pandemic: A Systematic Review 9 hours ago
- [preprint]A GIS-based framework for standardized environmental characterization in One-Health surveillance: a case study of HPAI monitoring in wetlands 9 hours ago
- First detection and transatlantic introduction of Influenza A(H3N2) subclade K (J.2.4.1) into Ecuador: insights from genomic sentinel surveillance 10 hours ago
- Assessment of influenza virus and coronavirus tropism, replication competence and disease severity in ex vivo and in vitro cultures of the human respiratory tract 1 days ago
- Characterization of bovine-derived H5N1 viruses expressing fluorescent and luminescent reporter proteins 1 days ago
[Go Top] [Close Window]


